Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus
β Scribed by W-Y. CHANG; C-J. CHEN; S-N. LU; S-L. YOU; W-L. CHUANG; S-C. CHEN; W-P. SU; L-Y. WANG; M-Y. HSIEH; M-M. WU; T-Y. TAI
- Book ID
- 118704185
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 350 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
surface antigen (HBsAg) but also in patients with "resolved" HBV infection. 5,6 In a retrospective analysis of lymphoma patients who were HBsAg-negative and anti-HBV core antigen (anti-HBc) positive, 5 of the 21 patients who received chemotherapy plus rituximab, an anti-CD20 antibody, developed hepa
A novel DNA virus, TT virus (TTV), was identified in a Japanese patient with posttransfusion hepatitis. The epidemiology and etiological role of this virus have not been elucidated. We investigated the epidemiology of TTV infection in hepatitis C virus (HCV) high endemic and low endemic areas, R tow
## Abstract Serum samples from 1,765 consecutive Sardinian blood donors, negative for hepatitis B surface antigen (HBsAg) and for antibodies to human immunodeficiency virus (HIV) (antiβHIV), were evaluated for the presence of antibodies to hepatitis C virus (antiβHCV) by secondβgeneration ELISA. An